原发性前列腺癌组织PSMA免疫组化表达模式对PSMA PET/CT分期的预测价值
该前瞻性研究纳入104例高危或中危前列腺癌患者,根治性前列腺切除术前接受[68Ga]Ga-PSMA-11 PET/CT,评估穿刺活检与全标本PSMA免疫组化表达的一致性,并检验活检PSMA表达对PET/CT SUVmax的预测作用。结果显示活检与膀胱前列腺块PSMA表达高度一致(AC1=0.8),活检及索引病灶IRS均为SUVmax的独立预测因子。
要点
- 前列腺癌阳性穿刺活检与全标本的PSMA免疫组化表达高度一致(AC1=0.8)
- 活检阳性穿刺及索引病灶的PSMA IRS均是PET/CT SUVmax的独立预测因子
- 术前评估PSMA免疫组化表达可能有助于制定更精准的个体化诊断路径
核心结论
- 前列腺癌阳性穿刺活检的PSMA免疫组化表达与全标本高度相关。
- PSMA表达程度是SUVmax的独立预测因子。
- 术前评估PSMA免疫组化表达可能影响更准确、个体化的诊断路径制定。
研究设计与样本
- 前瞻性纳入2021年6月至2023年7月间104例高危或中危前列腺癌患者。
- 患者均在根治性前列腺切除术前接受[68Ga]Ga-PSMA-11 PET/CT。
- 采用免疫反应评分(IRS)分析PSMA免疫组化表达。
- 使用Gwet一致性系数(AC1)评估活检与最终标本的相关性,回归模型检验预测作用。
主要发现
- 活检与膀胱前列腺块PSMA表达呈强相关(AC1=0.8,CI 0.7-0.9,p<0.01)。
- 多变量线性回归显示,前列腺癌阳性穿刺活检的IRS是SUVmax的显著预测因子(β=3.3,CI 1.5-7.5,p<0.01)。
- 索引病灶的IRS也是SUVmax的显著预测因子(β=4.9,CI 1.8-13,p<0.01)。
临床怎么用
- 术前可结合穿刺活检PSMA免疫组化表达评估PET/CT SUVmax水平。
- PSMA免疫组化表达评估可能辅助制定更个体化的分期诊断路径。
局限性
- 免疫组化判读为手动解释。
- 存在模型过拟合可能。
- 随访时间短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: In recent studies, prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has shown accuracy in staging patients diagnosed with prostate cancer. Here, we aim to evaluate the correlation between PSMA immunohistochemical characteristics of prostate cancer (PCa)-positive biopsy cores and whole-mount specimens, and test the predictive role of PSMA expression in biopsy samples for staging PSMA PET/CT. METHODS: A total of 104 patients with high- or intermediate-risk PCa who underwent [68Ga]Ga-PSMA-11 PET/CT before radical prostatectomy were prospectively selected between June 2021 and July 2023. The analysis of immunohistochemical PSMA expression was performed using the Immunoreactive Score (IRS). The correlation between biopsy and final specimen was evaluated using Gwet's agreement coefficient for ordinal variables (AC1). Regression models tested the immunohistochemical PSMA expression in biopsy/vesicoprostatic block and the PSMA PET/CT maximum standardized uptake value (SUVmax). KEY FINDINGS AND LIMITATIONS: A statistically significant strong correlation was found between PSMA expression in biopsy and vesicoprostatic block (AC1 = 0.8 [confidence interval {CI} 0.7-0.9], p < 0.01). According to the multivariable linear regression models, the IRSs of both the PCa-positive biopsy cores and the index lesion were statistically significant predictors of SUVmax (β = 3.3, CI 1.5-7.5, p < 0.01 and β = 4.9, CI 1.8-13, p < 0.01, respectively). Limitations include manual interpretation of immunohistochemistry, potential model overfitting, and a short follow-up. CONCLUSIONS AND CLINICAL IMPLICATIONS: The immunohistochemical analysis of PSMA expression in PCa-positive biopsy cores showed a high correlation with the whole-mount specimen. The degree of PSMA expression is an independent predictor of SUVmax. The assessment of immunohistochemical PSMA expression in a preoperative setting may have implications for determining a more accurate, patient-specific diagnostic pathway.
引用
- Ambrosini F, Piol N, Bauckneht M, et al. Immunohistochemical Prostate-specific Membrane Antigen (PSMA) Expression Patterns of Primary Prostate Cancer Tissue as a Determining Factor for Prostate Cancer Staging with PSMA Positron Emission Tomography/Computed Tomography. Eur Urol Oncol. 2025. PMID: 40307089. doi:10.1016/j.euo.2025.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。